Insider · CIK 0001512985

DesJardin Michael A.

Reports to the SEC for 2 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001512985

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−127K sh	$116.50	−$14.8M	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−10.5K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−14.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−20.7K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−13.8K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−5,236 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−31.4K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−4,285 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−12.9K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−21.4K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−10.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−5,174 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Technical Operations	DDisposition to Issuer	−5,174 sh	—	—	0
2023-03-02	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	+3,629 sh	$14.93	+$54.2K	125,815
2023-03-02	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	+743 sh	$17.19	+$12.8K	126,558
2023-03-02	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−3,629 sh	—	—	0
2023-03-02	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−743 sh	—	—	0
2023-01-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	+54.3K sh	—	—	149,087
2023-01-05	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, Technical Operations	FTax Payment	−26.9K sh	$113.24	−$3.05M	122,186
2023-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSUs)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−12.1K sh	—	—	0
2023-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSUs)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−10.5K sh	—	—	10,479
2023-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSUs)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−7,141 sh	—	—	14,283
2023-01-05	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−7,257 sh	—	—	0
2023-01-05	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−1,966 sh	—	—	0
2023-01-05	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−4,834 sh	—	—	0
2023-01-05	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−10.5K sh	—	—	5,236
2023-01-04	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSUs)A Award	EVP, Technical Operations	AAward	+20.7K sh	—	—	20,697
2023-01-01	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	+21.8K sh	—	—	104,395
2023-01-01	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, Technical Operations	FTax Payment	−9,561 sh	$113.80	−$1.09M	94,834
2023-01-01	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−21.8K sh	—	—	0
2022-12-27	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP, Technical Operations	AAward	+21.8K sh	—	—	21,772
2022-12-27	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP, Technical Operations	AAward	+15.7K sh	—	—	15,718
2022-06-01	Horizon Therapeutics Public Ltd CoA Award	EVP, Technical Operations	AAward	+277 sh	—	—	82,623
2022-04-12	Horizon Therapeutics Public Ltd CoS Sale	EVP, Technical Operations	SSale	−9,150 sh	$112.55	−$1.03M	93,410
2022-04-12	Horizon Therapeutics Public Ltd CoS Sale	EVP, Technical Operations	SSale	−11.1K sh	$113.60	−$1.26M	82,346
2022-03-02	Horizon Therapeutics Public Ltd CoS Sale	EVP, Technical Operations	SSale	−21.5K sh	$97.05	−$2.08M	116,078
2022-03-02	Horizon Therapeutics Public Ltd CoS Sale	EVP, Technical Operations	SSale	−13.5K sh	$97.42	−$1.32M	102,560
2022-01-21	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	+3,679 sh	—	—	139,385
2022-01-21	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, Technical Operations	FTax Payment	−1,825 sh	$86.42	−$158K	137,560
2022-01-21	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSUs)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−3,679 sh	—	—	0
2022-01-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	+53.7K sh	—	—	144,681
2022-01-05	Horizon Therapeutics Public Ltd CoA Award	EVP, Technical Operations	AAward	+32.3K sh	—	—	176,982
2022-01-05	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, Technical Operations	FTax Payment	−41.3K sh	$101.84	−$4.2M	135,706
2022-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−12.3K sh	—	—	0
2022-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−12.1K sh	—	—	12,095
2022-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−10.5K sh	—	—	20,957
2022-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−9,222 sh	—	—	9,223
2022-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Technical Operations	MExercise/Conversion	−9,678 sh	—	—	4,834
2022-01-04	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award	EVP, Technical Operations	AAward	+21.4K sh	—	—	21,424
2021-07-28	Horizon Therapeutics Public Ltd CoA Award	EVP, Technical Operations	AAward	+7,257 sh	—	—	94,544

Recent filings

Accepted (ET)
Oct 64
DesJardin Michael A.0001209191-23-052360
SEC(opens sec.gov)
Mar 64
DesJardin Michael A.0001209191-23-016340
SEC(opens sec.gov)
Jan 64
DesJardin Michael A.0001209191-23-002437
SEC(opens sec.gov)

Companies

Address

C/O JAZZ PHARMACEUTICALS, INC. 3180 PORTER DRIVE

PALO ALTO, CA, 94304